David Geffen

2.0k total citations
65 papers, 869 citations indexed

About

David Geffen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, David Geffen has authored 65 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Cancer Research and 14 papers in Pathology and Forensic Medicine. Recurrent topics in David Geffen's work include Breast Cancer Treatment Studies (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and HER2/EGFR in Cancer Research (6 papers). David Geffen is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and HER2/EGFR in Cancer Research (6 papers). David Geffen collaborates with scholars based in Israel, United States and Switzerland. David Geffen's co-authors include Samuel Ariad, Netta Sion‐Vardy, L. Bodner, Michael R. Nash, Daniel Benharroch, Michael Koretz, Salomon M. Stemmer, Georgeta Fried, Marianne Amir and Bella Kaufman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

David Geffen

61 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Geffen Israel 17 396 296 182 175 154 65 869
Yasuyuki Kojima Japan 24 512 1.3× 365 1.2× 228 1.3× 290 1.7× 106 0.7× 91 1.5k
Janine Bell United Kingdom 10 423 1.1× 158 0.5× 118 0.6× 113 0.6× 56 0.4× 11 1.0k
Hind M’rabti Morocco 14 355 0.9× 106 0.4× 89 0.5× 182 1.0× 55 0.4× 91 765
C. Gallagher United Kingdom 17 393 1.0× 102 0.3× 469 2.6× 205 1.2× 124 0.8× 46 1.2k
Catherine O’Hara United Kingdom 14 179 0.5× 103 0.3× 140 0.8× 193 1.1× 367 2.4× 25 861
Noureddine Benjaafar Morocco 16 392 1.0× 114 0.4× 122 0.7× 142 0.8× 89 0.6× 105 889
Merlın Hamre United States 18 425 1.1× 173 0.6× 212 1.2× 303 1.7× 48 0.3× 29 1.1k
Elisabeth Pras Netherlands 24 514 1.3× 133 0.4× 134 0.7× 417 2.4× 77 0.5× 35 1.6k
Sameer A. Patel United States 11 448 1.1× 261 0.9× 71 0.4× 101 0.6× 59 0.4× 48 1.1k
James E. Goodnight United States 20 444 1.1× 134 0.5× 246 1.4× 668 3.8× 106 0.7× 46 1.4k

Countries citing papers authored by David Geffen

Since Specialization
Citations

This map shows the geographic impact of David Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Geffen more than expected).

Fields of papers citing papers by David Geffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Geffen. The network helps show where David Geffen may publish in the future.

Co-authorship network of co-authors of David Geffen

This figure shows the co-authorship network connecting the top 25 collaborators of David Geffen. A scholar is included among the top collaborators of David Geffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Geffen. David Geffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraenkel, Merav, Victor Novack, Michael Koretz, et al.. (2022). Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study. npj Breast Cancer. 8(1). 21–21. 8 indexed citations
2.
Stemmer, Salomon M., Mariana Steiner, Shulamith Rizel, et al.. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. npj Breast Cancer. 5(1). 41–41. 23 indexed citations
3.
4.
Evron, Ella, Georgeta Fried, Bella Kaufman, et al.. (2018). Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer. Annals of Oncology. 30(3). 412–417. 36 indexed citations
5.
Stemmer, Salomon M., Shulamith Rizel, David Geffen, et al.. (2017). Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry. npj Breast Cancer. 3(1). 32–32. 68 indexed citations
6.
Granek, Leeat, et al.. (2014). Early Exposure to a Clinical Oncology Course During the Preclinical Second Year of Medical School. Academic Medicine. 90(4). 454–457. 15 indexed citations
7.
Geffen, David, et al.. (2014). Breast Cancer in Bedouin-Arab Patients in Southern Israel: Epidemiologic and Biologic Features in Comparison with Jewish Patients. Asian Pacific Journal of Cancer Prevention. 15(18). 7533–7537. 5 indexed citations
8.
Grenader, Tal, Rinat Yerushalmi, Georgeta Fried, et al.. (2014). The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort. Oncology. 87(1). 1–6. 26 indexed citations
9.
Fraenkel, Merav, Victor Novack, Yair Liel, et al.. (2013). Association between Bone Mineral Density and Incidence of Breast Cancer. PLoS ONE. 8(8). e70980–e70980. 22 indexed citations
10.
Geffen, David, et al.. (2013). Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine. Journal of Chemotherapy. 25(3). 176–180. 4 indexed citations
11.
12.
Novack, Victor, et al.. (2011). The prognostic importance of cathepsin D and E-cadherin in early breast cancer: A single-institution experience. Oncology Letters. 2(6). 1183–1190. 11 indexed citations
13.
Wolf, Ido, Ronnie Shapira‐Frommer, Shulamit Rizel, et al.. (2007). Association between standard clinical and pathologic characteristics and the 21‐gene recurrence score in breast cancer patients. Cancer. 112(4). 731–736. 54 indexed citations
14.
Bobilev, Dmitri, et al.. (2006). Combined Multimodal Approach to the Treatment of Metastatic Anal Carcinoma: Report of a Case and Review of the Literature. Oncology Research and Treatment. 29(1-2). 30–32. 22 indexed citations
15.
Geffen, David, Howard J. Zirkin, Wilmosh Mermershtain, Yoram Cohen, & Samuel Ariad. (1998). Metastatic Angiosarcoma of the Spleen After Accidental Radiation Exposure. American Journal of Clinical Oncology. 21(2). 167–170. 6 indexed citations
16.
Ariad, Samuel, et al.. (1997). Gluteal manifestation of advanced Hodgkin's disease. Skeletal Radiology. 26(10). 622–625. 7 indexed citations
17.
Ariad, Samuel, et al.. (1997). Myasthenia Gravis Associated with Malignant Mixed Mullerian Tumor of the Uterus. Gynecologic Oncology. 64(3). 510–515. 5 indexed citations
18.
Benharroch, Daniel, et al.. (1993). Basal Cell Carcinoma of the Male Nipple Case Report and Review of the Literature. The Journal of Dermatologic Surgery and Oncology. 19(2). 137–139. 23 indexed citations
19.
Stemmer, Salomon M., David Geffen, Jed Goldstein, & Yoram Cohen. (1993). Primary Small Noncleaved Cell Lymphoma of the Liver. Journal of Clinical Gastroenterology. 16(1). 65–69. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuyuki Kojima Breakdown of academic impact, for papers by Janine Bell Breakdown of academic impact, for papers by Hind M’rabti Breakdown of academic impact, for papers by C. Gallagher Breakdown of academic impact, for papers by Catherine O’Hara Breakdown of academic impact, for papers by Noureddine Benjaafar Breakdown of academic impact, for papers by Merlın Hamre Breakdown of academic impact, for papers by Elisabeth Pras Breakdown of academic impact, for papers by Sameer A. Patel Breakdown of academic impact, for papers by James E. Goodnight
Rankless by CCL
2026